Ingrid Hein is a Medical Reporter at Conference News. She covers critical health topics including the Coronavirus, CDC, FDA, Monkeypox, and Omicron, providing insightful analysis and updates on public health issues. Ingrid's work has also been featured in MedPage Today.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Ingrid's coverage primarily revolves around health, healthcare & pharmaceuticals, with a strong emphasis on citing data to support her articles. She seems particularly interested in reporting on medical research findings and government announcements related to health and medicine.
Given her focus on citing data and government announcements, Ingrid would likely be receptive to pitches that provide access to reliable studies or experts who can offer evidence-based insights into current trends in healthcare, COVID-19, vaccines, infectious diseases, and medical research. Sources with access to relevant official statements or exclusive data may also capture her attention.
It appears that Ingrid does not have a specific geographic focus but rather covers global matters within the realm of health and medicine.
This information evolves through artificial intelligence and human feedback. Improve this profile .
New high-risk conditions added as well, including chronic kidney disease and asthma
By: Ingrid Hein
Better outcomes for people with cancer or heart disease, matched cohort finds
The vaccine neutralizes Lyme-causing bacteria in the tick before it can get to the human
Randomized platform trial suggests no reason for routine use
Vaccine given during pregnancy produced antibodies that were transferred to infants
During BA.5 wave in Italy, Omicron-directed boosters topped another dose of monovalent vaccine
Antibiotics can treat this tick infection tied to exposure to rustic cabins, camping, and caves
IVF and sperm injections less effective after infection, Chinese researchers say
Jury still out on whether infection can cause permanent seminal damage, however
Lack of rapid testing and payer restrictions are creating barriers, experts say
(833) 317-6278 
